SETD2 histone modifier loss in aggressive GI stromal tumours.
about
High-density array-CGH with targeted NGS unmask multiple noncontiguous minute deletions on chromosome 3p21 in mesotheliomaType II enteropathy-associated T-cell lymphoma features a unique genomic profile with highly recurrent SETD2 alterations.H3K36 methyltransferases as cancer drug targets: rationale and perspectives for inhibitor developmentSETting the Stage for Cancer Development: SETD2 and the Consequences of Lost Methylation.Histone methyltransferase SETD2 modulates alternative splicing to inhibit intestinal tumorigenesis.
P2860
SETD2 histone modifier loss in aggressive GI stromal tumours.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
SETD2 histone modifier loss in aggressive GI stromal tumours.
@en
type
label
SETD2 histone modifier loss in aggressive GI stromal tumours.
@en
prefLabel
SETD2 histone modifier loss in aggressive GI stromal tumours.
@en
P2093
P2860
P50
P1433
P1476
SETD2 histone modifier loss in aggressive GI stromal tumours.
@en
P2093
Alexander Chung
Alisa Noor Hidayah Sairi
Cedric Chuan Young Ng
Hock Soo Ong
Iain Beehuat Tan
Jia Liang Loh
John R McPherson
Khee Chee Soo
Kiat Hon Lim
P2860
P304
P356
10.1136/GUTJNL-2015-309482
P407
P577
2015-09-03T00:00:00Z